Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 16

    1.

    Resistance of leukemic stem-like cells in AML cell line KG1a to natural killer cell-mediated cytotoxicity.

    She M, Niu X, Chen X, Li J, Zhou M, He Y, Le Y, Guo K.

    Cancer Lett. 2012 May 28;318(2):173-9. doi: 10.1016/j.canlet.2011.12.017. Epub 2011 Dec 21.

    PMID:
    22198207
    [PubMed - indexed for MEDLINE]
    2.

    Growth inhibition of imatinib-resistant CML cells with the T315I mutation and hypoxia-adaptation by AV65--a novel Wnt/β-catenin signaling inhibitor.

    Nagao R, Ashihara E, Kimura S, Strovel JW, Yao H, Takeuchi M, Tanaka R, Hayashi Y, Hirai H, Padia J, Strand K, Maekawa T.

    Cancer Lett. 2011 Dec 15;312(1):91-100. Epub 2011 Aug 17.

    PMID:
    21906872
    [PubMed - indexed for MEDLINE]
    3.

    Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.

    Ishitsuka K, Kunami N, Katsuya H, Nogami R, Ishikawa C, Yotsumoto F, Tanji H, Mori N, Takeshita M, Miyamoto S, Tamura K.

    Cancer Lett. 2012 Apr 28;317(2):218-25. Epub 2011 Dec 2.

    PMID:
    22138435
    [PubMed - indexed for MEDLINE]
    4.

    Notch-ing from T-cell to B-cell lymphoid malignancies.

    Mirandola L, Comi P, Cobos E, Kast WM, Chiriva-Internati M, Chiaramonte R.

    Cancer Lett. 2011 Sep 1;308(1):1-13. Review.

    PMID:
    21652011
    [PubMed - indexed for MEDLINE]
    5.

    Astragalin heptaacetate-induced cell death in human leukemia cells is dependent on caspases and activates the MAPK pathway.

    Burmistrova O, Quintana J, Díaz JG, Estévez F.

    Cancer Lett. 2011 Oct 1;309(1):71-7. Epub 2011 Jun 11.

    PMID:
    21658841
    [PubMed - indexed for MEDLINE]
    6.

    Reversal of Imatinib resistance in BCR-ABL-positive leukemia after inhibition of the Na+/H+ exchanger.

    Jin W, Li Q, Lin Y, Lu Y, Li H, Wang L, Hu R, Ma L, Wang J, Pang T.

    Cancer Lett. 2011 Sep 1;308(1):81-90. Epub 2011 May 14.

    PMID:
    21576001
    [PubMed - indexed for MEDLINE]
    7.

    Pim 1 kinase inhibitor ETP-45299 suppresses cellular proliferation and synergizes with PI3K inhibition.

    Blanco-Aparicio C, Collazo AM, Oyarzabal J, Leal JF, Albarán MI, Lima FR, Pequeño B, Ajenjo N, Becerra M, Alfonso P, Reymundo MI, Palacios I, Mateos G, Quiñones H, Corrionero A, Carnero A, Pevarello P, Lopez AR, Fominaya J, Pastor J, Bischoff JR.

    Cancer Lett. 2011 Jan 28;300(2):145-53. Epub 2010 Nov 3.

    PMID:
    21051136
    [PubMed - indexed for MEDLINE]
    8.

    Carboxyamidotriazole inhibits cell growth of imatinib-resistant chronic myeloid leukaemia cells including T315I Bcr-Abl mutant by a redox-mediated mechanism.

    Corrado C, Raimondo S, Flugy AM, Fontana S, Santoro A, Stassi G, Marfia A, Iovino F, Arlinghaus R, Kohn EC, Leo GD, Alessandro R.

    Cancer Lett. 2011 Jan 28;300(2):205-14. Epub 2010 Oct 30.

    PMID:
    21041018
    [PubMed - indexed for MEDLINE]
    9.

    Steroid hormone receptors in cancer development: a target for cancer therapeutics.

    Ahmad N, Kumar R.

    Cancer Lett. 2011 Jan 1;300(1):1-9. Review.

    PMID:
    20926181
    [PubMed - indexed for MEDLINE]
    10.

    Nuclear Factor-κB modulates cellular glutathione and prevents oxidative stress in cancer cells.

    Meng Q, Peng Z, Chen L, Si J, Dong Z, Xia Y.

    Cancer Lett. 2010 Dec 18;299(1):45-53.

    PMID:
    20810208
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    11.

    Imatinib treatment in chronic myelogenous leukemia: What have we learned so far?

    Breccia M, Efficace F, Alimena G.

    Cancer Lett. 2011 Jan 28;300(2):115-21. Epub 2010 Nov 12. Review.

    PMID:
    21074936
    [PubMed - indexed for MEDLINE]
    12.

    HDAC inhibitors with different gene regulation activities depend on the mitochondrial pathway for the sensitization of leukemic T cells to TRAIL-induced apoptosis.

    Morales JC, Ruiz-Magaña MJ, Carranza D, Ortiz-Ferrón G, Ruiz-Ruiz C.

    Cancer Lett. 2010 Nov 1;297(1):91-100. Epub 2010 May 23.

    PMID:
    20580868
    [PubMed - indexed for MEDLINE]
    13.

    Heat Shock Protein translocation induced by membrane fluidization increases tumor-cell sensitivity to chemotherapeutic drugs.

    Dempsey NC, Ireland HE, Smith CM, Hoyle CF, Williams JH.

    Cancer Lett. 2010 Oct 28;296(2):257-67. Epub 2010 May 11.

    PMID:
    20462687
    [PubMed - indexed for MEDLINE]
    14.

    Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance.

    Zhi L, Wang M, Rao Q, Yu F, Mi Y, Wang J.

    Cancer Lett. 2010 Oct 1;296(1):65-73. Epub 2010 May 4.

    PMID:
    20444543
    [PubMed - indexed for MEDLINE]
    15.

    Breakages at common fragile sites set boundaries of amplified regions in two leukemia cell lines K562 - Molecular characterization of FRA2H and localization of a new CFS FRA2S.

    Pelliccia F, Bosco N, Rocchi A.

    Cancer Lett. 2010 Dec 18;299(1):37-44. Epub 2010 Sep 18.

    PMID:
    20851513
    [PubMed - indexed for MEDLINE]
    16.

    Inhibition of cyclooxygenase-2-dependent survivin mediates decursin-induced apoptosis in human KBM-5 myeloid leukemia cells.

    Ahn Q, Jeong SJ, Lee HJ, Kwon HY, Han I, Kim HS, Lee HJ, Lee EO, Ahn KS, Jung MH, Zhu S, Chen CY, Kim SH.

    Cancer Lett. 2010 Dec 8;298(2):212-21. Epub 2010 Jul 31.

    PMID:
    20673699
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Recent activity

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      Write to the Help Desk